|
Market Closed -
Boerse Muenchen
00:44:22 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.3620 EUR | 0.00% |
|
0.00% | +21.68% |
| 09-02 | Nicox S.A. Announces Appointment of Doug Hubatsch as Chief Scientific Advisor | CI |
| 08-27 | The FDA will issue its decision on Nicox's NCX 470 by the end of next April |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NICOX SA | Specialty & Advanced Pharmaceuticals | 0.00% | 0.00% | - | - | - | 39.02M |
-
|
-
|
-
|
- Stock Market
- Stocks
- ALCOX Stock
- NXOA Stock
- Charts Nicox SA
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
